「#Finance & Performance」Contents List
-
IRFY23/3 H1 Earnings Results
IRFY23/3 H1 Earnings Results
-
IRDifference Between FY23/3 Q2 Earnings Forecast and Actual Results & Downward Revision of Full-Year Earnings Forecast
IRDifference Between FY23/3 Q2 Earnings Forecast and Actual Results & Downward Revision of Full-Year Earnings Forecast
-
IRForeign Exchange Gain
IRForeign Exchange Gain
-
IRSigning of Share Purchase Agreement for Chinese Subsidiary Sale
IRSigning of Share Purchase Agreement for Chinese Subsidiary Sale
-
IRFY23/3 Q1 Earnings Results
IRFY23/3 Q1 Earnings Results
-
IRDifference Between FY23/3 Q1 Earnings Forecast and Actual Results (Sales Below Forecast, Earnings Above Forecast)
IRDifference Between FY23/3 Q1 Earnings Forecast and Actual Results (Sales Below Forecast, Earnings Above Forecast)
-
IRExtraordinary Gain on Chinese Receivables (Disclosure Update), Foreign Exchange Gain, and Impairment Loss
IRExtraordinary Gain on Chinese Receivables (Disclosure Update), Foreign Exchange Gain, and Impairment Loss
-
IRINCJ Loan Extension
IRINCJ Loan Extension
-
IR(Disclosure Update) Extraordinary Gain on Chinese Receivables
IR(Disclosure Update) Extraordinary Gain on Chinese Receivables
-
IRDifference Between FY22/3 Earnings Forecast and Actual Results & Recording of Extraordinary Loss (Impairment)
IRDifference Between FY22/3 Earnings Forecast and Actual Results & Recording of Extraordinary Loss (Impairment)
-
IRFY22/3 Earnings Results
IRFY22/3 Earnings Results
-
IRExtraordinary Gain on Chinese Receivables
IRExtraordinary Gain on Chinese Receivables
-
IRRenewal of Patent Cross License Agreement with Innolux Corporation
IRRenewal of Patent Cross License Agreement with Innolux Corporation
-
IRCompletion of Exercise of 12th Series Stock Acquisition Rights
IRCompletion of Exercise of 12th Series Stock Acquisition Rights
-
IR(Disclosure Update) Holding of Extraordinary Shareholders Meeting and Fixing of Record Date, Capital Reduction, and Surplus Appropriation
IR(Disclosure Update) Holding of Extraordinary Shareholders Meeting and Fixing of Record Date, Capital Reduction, and Surplus Appropriation
-
IRFull-Year Earnings Forecast Revision (Downward Sales Revision/Upward Earnings Revision) & Difference Between FY22/3 Q3 Earnings Forecast & Results
IRFull-Year Earnings Forecast Revision (Downward Sales Revision/Upward Earnings Revision) & Difference Between FY22/3 Q3 Earnings Forecast & Results
-
IRFY22/3 Q3 Earnings Results
IRFY22/3 Q3 Earnings Results
-
IRExtraordinary Gain on KOE Subsidiary Sale
IRExtraordinary Gain on KOE Subsidiary Sale
-
IRAmicable Settlement with Tianma Microelectronics
IRAmicable Settlement with Tianma Microelectronics
-
IRHolding of Extraordinary Shareholders Meeting and Fixing of Record Date, Capital Reduction, and Surplus Appropriation
IRHolding of Extraordinary Shareholders Meeting and Fixing of Record Date, Capital Reduction, and Surplus Appropriation
